A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Condition: Prostate Cancer · Sponsor: Sumitomo Pharma America, Inc.
About this study
This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (96)
| Urology Centers of Alabama | Homewood, Alabama, United States | — |
| Urology Associates of Mobile | Mobile, Alabama, United States | — |
| Dignity Health | Phoenix, Arizona, United States | — |
| Arizona Urology Specialists, PLLC | Tucson, Arizona, United States | — |
| Arkansas Urology Research Center | Little Rock, Arkansas, United States | — |
| City of Hope | Duarte, California, United States | — |
| Urology Associates of Central California | Fresno, California, United States | — |
| UCSD | La Jolla, California, United States | — |
| USC Norris Cancer Center | Los Angeles, California, United States | — |
| Tower Urology | Los Angeles, California, United States | — |
| VA Greater Los Angeles Medical Center | Los Angeles, California, United States | — |
| Tri Valley Urology | Murrieta, California, United States | — |
+ 84 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05467176